Advanced Renal Cell Carcinoma Completed Phase 3 Trials for Tivozanib (DB11800)

Also known as: Advanced Renal cell carcinoma

DBCOND0032596 (Advanced Renal Cell Carcinoma)Completed3 IdentifierTitlePurposeDrugs
NCT01030783A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell CarcinomaTreatment
NCT01076010An Extension Treatment Protocol for Subjects Who Have Participated in a Phase 3 Study of Tivozanib Versus Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301)Treatment